Today, far too often, canine cancer is not detected until in its late stages, which often means less time to act to help our dogs. Our goal is to develop tools to detect cancers earlier, providing more time to create effective and personalized cancer treatments that will extend the life and well-being of affected dogs.
Sentinel Biomedical’s core research is focused on the following:
1) identification of genetic signatures that have diagnostic and/or prognostic significance for canine cancers
2) comparison of the genetic basis of canine and human cancers
3) tracking geographic cancer clusters to determine potential environmental impact
By taking a comparative approach to our research, we aim to accelerate the pace of discoveries leading to improved diagnosis and treatment both for canine and human patients.